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ABSTRACT
Objective: To evaluate the effectiveness of auricular acupuncture in the pain of cancer 
patients receiving chemotherapy and to verify if there were alterations in the use of 
analgesics after the application of this intervention. Method: Randomized controlled 
trial with cancer patients with complaints of pain greater than or equal to four in the 
Numerical Pain Scale. Two parallel groups were created, an Experimental group, which 
received auricular acupuncture at energy balance points and at points indicated for the 
treatment of pain, and a Placebo group, in which fixed placebo points were used. Both 
groups received the application of semipermanent needles in eight sessions. Results: 31 
cancer patients participated in the study. After the eight auricular acupuncture sessions, 
there was a significant difference between the groups regarding the reduction of pain 
intensity (p < 0.001) and of the use of medications (p < 0.05). Conclusion: Auricular 
acupuncture was effective in reducing the pain of patients receiving chemotherapy. 
Brazilian Registry of Clinical Trials: RBR-6k3rqh.
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INTRODUCTION
Cancer cases have increased in recent years, as have the 
prevalence of the symptoms presented by patients during 
the disease, especially the occurrence of pain(1-2). 
Cancer pain is a symptom related to multiple factors and 
defined as simultaneous sensations of acute and chronic pain 
at different levels, associated with the spread of cancerous 
cells in the body. It is a consequence of cancer treatment, 
including chemotherapy, or cancer-related conditions such 
as wound pain. Cancer pain is usually described as imprecise, 
hurtful, painful, frightening or as an unbearable pain, with 
episodes of intense pain that appear along with difficulties 
sleeping, irritability, depression, suffering, isolation, despair 
and helplessness(3). It is considered a challenge for health 
services and for the multi-professional team.
Despite having received more attention in recent 
years, especially after the approval of the WHO Analgesic 
Ladder(4), about 40% to 50% of the cases of cancer pain 
receive inadequate treatment, since they depend on a combi-
nation of factors, such as evaluation and the treatment itself, 
and require complex decisions for its management(5-6). This 
international method supports the use of accessible drugs, 
prescribed according to the intensity of pain reported by 
each individual(7). 
However, even with simple strategies available for man-
aging cancer pain, its prevalence indicates the urgency of 
developing actions that lead to more favorable patient out-
comes(8). Health services can incorporate complementary 
and safe techniques in an attempt to provide better pain 
management, especially when conventional treatments 
become limited(9). 
In this context, we highlight Auricular Acupuncture (AA), 
which has shown satisfactory results in the management of 
cancer pain(10-11). This technique, originated in Traditional 
Chinese Medicine (TCM), has been described for about 
2,500 years and seeks the harmony and balance of the body 
through stimuli at specific points of the auricle, which have 
direct effects on the central nervous system (CNS)(12-14).
For TCH, Qi (energy or life force) flows throughout 
the body through channels that pass through specific points 
connected to the functions of each organ. Thus, when Qi 
is unbalanced, these points can be stimulated, altering the 
flow of energy and recovering the health of the individual(15). 
According to this theory, when the auricular acupoints are 
stimulated, they cause changes in Qi and restore balance in 
the body(16). 
However, the evidence supporting the use of AA for 
the management of cancer pain is still incipient, due to the 
methodological commitment of studies available in the sci-
entific literature, which present a high risk of bias(9,17). Thus, 
studies that prove the effectiveness of AA for the treatment 
of this symptom are necessary to strengthen the evidence 
and encourage the use of the technique. 
This study aimed to evaluate the effectiveness of Auricular 
Acupuncture in the pain of cancer patients receiving chemo-
therapy and to verify if there were alterations in the use of 
analgesics after the application of this intervention. 
METHOD
Randomized controlled trial, with a 1:1 parallel design.
The inclusion criteria for participation in the study were: 
receiving chemotherapy treatment and being mentally ori-
ented; presenting pain ≥ four in the Numerical Pain Scale 
(EN); being followed up in the High Complexity Care Unit; 
accepting the needle treatment and being at least 18 years 
old. The exclusion criteria were the presence of lesions and/
or edema on the ear, absence of the auricle or alterations 
that would contraindicate the insertion of needles, allergy to 
micropore tape, terminal patients and/or patients with head 
and neck cancer, due to possible alterations in the transmis-
sion of AA stimuli, and anticoagulant users, due to the risk 
of bleeding after needle placement. 
The study was carried out in the city of Alfenas, located 
in the state of Minas Gerais. The participants were can-
cer patients who received chemotherapy treatment at the 
UNACON of the House of Charity Nossa Senhora do 
Perpétuo Socorro – Santa Casa of Alfenas, which autho-
rized the study. 
An intervention protocol based on previous studies was 
established(10,18). There were nine meetings, and eight sessions 
of AA with all participants, one session per week, with a 7-day 
interval between sessions. Seven days after the last session, 
participants returned to the ninth meeting, in which final 
evaluations, needle removal and inspection of the ear occurred. 
Due to the scarcity of studies determining the ideal size 
of auricular needles for the treatment of cancer pain, sterile, 
disposable, semi-permanent auricular needles, size 0.20 mm 
x 1.5 mm were chosen. In the first session, the application 
of the needles in the right auricle was standardized for both 
groups, alternating the auricle in the other sessions.
Participants were allocated into two groups, an 
Experimental Group and a Placebo Group. In the 
Experimental Group the acupoints used were Shenmen, 
Kidney, Sympathetic, Muscle Relaxation and the energy bal-
ance points, defined through the Five Elements theory. The 
Eye and Trachea points were applied to the Placebo Group. 
The Shenmen stimulates the brainstem and the cortex to 
receive, decode, modulate and condition the reflexes of the 
next acupoints, avoiding imbalances in the patient’s body 
and preventing new diseases. This point calms the heart and 
mind and has an analgesic function, through the release of 
endorphins(13-14). It is one of the most used points in pain 
treatments(11-12).
The Kidney Point stimulates the filtration of blood, 
releasing toxins and improving circulation. This point 
improves the function of the respiratory system, the endo-
crine glands and the excretory organs. The Sympathetic 
point accelerates and regulates the neurovegetative activity, 
balancing the sympathetic and parasympathetic functions 
by rebalancing the autonomic nervous system, which pro-
motes the general balance of the organism. This point has 
an important analgesic, anti-inflammatory and relaxation 
action of muscle fibers(13-14). The Muscular Relaxation point 
is indicated for pain, muscular tension, anxiety, depression, 
among others(13). 
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The Five Elements theory (pentagram) is part of the 
essence of TCM and is one of the principles and tools used 
to diagnose a person’s energy imbalance(19). The design of the 
Five Elements is based on the elements of nature (Wood, 
Fire, Earth, Metal and Water) and how they interrelate(14), 
according to the functions, energy and qualities of each ele-
ment to establish the balance of the organism(19). 
Each element is represented by an organ and a viscera 
(hollow organ) of the body, composing the Five Elements. 
This way, the Wood is associated with the liver and the gall-
bladder, the Fire with the heart and the small intestine, the 
Earth with the spleen/pancreas and the stomach, the Metal 
with the lungs and the large intestine and the Water with 
the kidney and the bladder(19). The elements exchange energy 
with each other, providing harmony to the person. 
When the elements are balanced, there is no disharmony 
in the pentagram, and the person is in the state of “health”. 
When there are energy changes caused by the exchange of 
altered energy between the elements, this relationship is com-
promised and the “disease” process, which can be slow and 
progressive, is established(14). Unbalance in the pentagram is 
diagnosed through anamnesis and the symptoms reported 
by each individual, evaluated according to the principles of 
CTM. Thus, according to this evaluation, the energy balance 
points are defined individually and correspond to the organ 
and the viscera that represent the element in which the body 
imbalance begins. From this, the points of the pentagram are 
used to restore the harmony and health of the individual(19).
The application of the points in the Experimental 
Group respected the following order: Shenmen, Kidney, 
Sympathetic, energy balance points and Muscle Relaxation. 
The minimum number of needles applied per session was five 
when there was imbalance of the element Water (Shenmen, 
Kidney, Sympathetic, Bladder and Muscle Relaxation), and 
the maximum was seven when the result indicated unbal-
ance of the Earth element (Shenmen, Kidney, Sympathetic, 
Spleen/Pancreas, stomach and muscle relaxation). In this 
group, the mean time per session was 40 minutes. 
In the Placebo Group, two fixed sham points, unrelated 
to pain, were used: Eye point and Trachea point(13-14), applied 
in that order. For  this group, the mean time per session was 
20 minutes.
The needles remained in the auricle for 7 days, except in 
specific cases where the session was rescheduled for partic-
ular reasons, such as malaise and tests. In these cases, there 
were variations of 2 to 3 days in the application of AA. 
After the intervention, the participants were informed 
about the hygiene and maintenance of the needles in the 
ear. The manual stimulation of the needles was not recom-
mended because the researchers would not have control of 
this action. The participants followed the orientations, and 
the needles remained fixed on the points until they returned 
to the next session. 
In cases of doubts or adverse reactions that could be related 
to AA, participants were instructed to contact the investigator. 
At the end of the study, those in the Placebo Group were invited 
to receive the same treatment offered to the Experimental 
Group, and one participant accepted the treatment.
The AA was conducted by a researcher, who has the 
necessary certification, guaranteeing the homogeneity of 
the technique. The evaluations were performed by a trained 
evaluator who was blinded to the allocation and who had 
no knowledge on AA treatment, and no participants were 
informed as to which group they belonged.
The characterization of the participants occurred at 
the first meeting through, an instrument developed by the 
researchers. The AA was applied in a reserved place, in a calm 
and safe environment, and the participants remained in the 
supine position due to the risk of dizziness or lipothymy(14).
Pain intensity was evaluated in the first and ninth meet-
ings, using the 11-point version of the EN, chosen because 
of its reliability in evaluating cancer pain(20). Participants 
chose score that best represented their pain. The pain level 
was compared at the beginning and at the end of the study. 
When assigning a score for pain, the symptom was classified 
as absent (0), mild (1-4), moderate (5-7), or severe (8-10)(21).
The use of analgesics was evaluated in the first and ninth 
meeting, through the participant’s report regarding the use 
of this medication in the previous 3 days. They were ques-
tioned about: the daily number of medications, the dosage 
used and the name of the medication, for confirmation of 
its class. After this, the medication was classified accord-
ing to the medications defined for each step of the WHO 
Analgesic Ladder, determining the participant’s position 
on the steps. Each participant was instructed to seek the 
appropriate physician before reducing any medication.
The follow-up evaluation was scheduled for 20 days after 
the final evaluation. However, the number of deaths that 
occurred next and the non-attendance of participants for 
the evaluation, due to health issues or without justification, 
made this evaluation impossible.
Participants were divided into the groups by simple 
randomization (biased coin method), and the researcher 
responsible for the intervention was also responsible for 
the randomization process, and did not participate in 
the evaluations.
The collected data were stored and arranged in a data-
base. Subsequently, they were transferred to the statistical 
program Statistical Package for Social Sciences (SPSS), ver-
sion 17.0, the software used for the statistical analysis of the 
study. For all analyzes, the level of significance was <0.05.
For the homogeneity test, the Pearson’s Chi-square test, 
the Fisher’s exact test and the Mann-Whitney test were 
applied according to the variable. To verify if there was a sig-
nificant difference between the groups, the Mann-Whitney 
test was applied.
The statistical power and effect size of the tests were 
analyzed using the programs GPower® 3.1 and PASS® 11, 
depending on the variable. In addition, a statistical power of 
95% was considered for all effect size analyzes. 
Participants signed an Informed Consent Form and 
received a copy. The study was registered in the Brazilian 
Registry of Clinical Trials (REBEC) portal: RBR-6k3rqh 
and approved by the Research Ethics Committee of 
UNIFAL-MG protocol no. 1330960, complying with 
Resolution 466/2012.
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RESULTS
The study population was approximately 1,070 people 
undergoing cancer treatment at UNACON. The sample 
was collected by active search divided in two stages, with 
two weeks each. The first stage occurred in December 2015, 
and the second in February 2016. Patients who were in this 
sector and who had no apparent lesions in the head and neck 
region were approached. 
Thus, 70 individuals were assessed for eligibility to par-
ticipate in the study. Of these, 31 met the inclusion criteria 
and were part of the initial sample. After randomization, 16 
participants were allocated in the Experimental Group and 15 
in the Placebo Group. During follow-up, there were losses, and 
at the end of the study, 11 participants were analyzed in the 
Experimental Group and 12 in the Placebo Group. The final 
sample was composed of 23 participants, as shown in Figure 1. 
Figure 1 – Flowchart of allocation, follow-up and analysis of the participants of the Experimental Group and the Placebo Group.
Inclusion Assessed for eligibility (n = 70)
Excluded (n = 39)
Did not meet inclusion criteria (n = 22)
Gave up to participate (n = 8)
Other reasons (n = 9)
Randomized (n = 31)
Allocation
Follow-up
Analysis
Allocated for intervention (n = 16)
Received intervention (n = 16)
Allocated for intervention (n = 15)
Received intervention (n = 15)
Discontinued intervention – deaths
and withdrawals (n = 5)
Discontinued intervention – deaths
and withdrawals (n = 3)
Analyzed (n = 11) Analyzed (n = 12)
The participants were characterized according to quan-
titative socio-demographic variables (Table 1) and qual-
itative clinical variables (Table 2), and the groups were 
homogeneous in relation to the variables age, education, 
gender, type of cancer, cancer stage, time of treatment and 
number of analgesics used.
Table 1 – Characterization of quantitative socio-demographic va-
riables – Alfenas, MG, Brazil, 2016.
Variables
Experimental  Group
(n = 11)
Mean ± SD
(Median)
Placebo Group
(n = 12)
Mean ± SD
(Median)
p-value
Age (years) 58.27 ± 10.09(59.00)
52.08 ± 7.99
(53.00) 0.116
Level of education 
(years)
8.55 ± 3.44
(6.00)
9.92 ± 3.91
(10.50) 0.391
Note: SD: standard-deviation. Application of the Mann-Whitney test.
Table 2 – Characterization of qualitative clinical variables – Alfe-
nas, MG, Brazil, 2016.
Variables
Experimental
Group
(n = 11) (%)
Placebo
Group
(n = 12) (%)
p-value
GenderF
Male 18.2 25.0
1.000
Female 81.8 75.0
Type of cancerF
Breast 63.6 41.7
0.414
Others 36.4 58.3
Cancer stageP
II 18.2 16.7
0.278III 27.3 58.3
IV 54.5 25.0
Time of treatment
(in months)F
0-12 63.6 25.0
0.100
> 12 36.4 75.0
Number of 
analgesics usedF
0-1 63.6 58.3
1.000
≥ 2 36.4 41.7
Note: F: Application of Fisher’s Exact Test; P: Application of the Chi-square 
Person’s test.
After the application of AA, a statistically significant 
difference in pain intensity between the groups (p <0.001) 
was observed and confirmed by the analysis of the statistical 
power and effect size. 
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The comparison between the mean pain intensity in the 
first and in the last evaluation showed that the Experimental 
Group started the study with moderate pain (mean ± 
SD: 7.36 ± 1.74), as did the Placebo Group (6.00 ± 1.5). 
However, at the end of the study, the group receiving true 
AA had pain classified as mild (2.09 ± 1.44), while the group 
receiving sham AA maintained the mean pain at baseline 
level (6.33 ± 2.14) (Table 3).
Table 3 – Intergroup evaluation related to pain intensity – Alfenas, MG, Brazil, 2016.
Ev.
Experimental Group
(n = 11)
Mean ± SD
(Median)
Placebo Group
(n = 12)
Mean ± SD
(Mediana)
p-value
Statistical power
(1 – error β)1
Effect size2
Initial 7.36 ± 1.74(7.00)
6.00 ± 1.5
(6.00) 0.090
0.4621
0.8372
Final 2.09 ± 1.44(2.00)
6.33 ± 2.14
(5.50) <0.001*
0.9991
2.3242
Note: Ev.: Evaluation; *: p-value < 0,05. Application of Mann-Whitney test.
In addition to reduction of pain intensity, the comparison 
between the groups also showed significant differences in 
daily doses of analgesics (p = 0.010), number of analgesics 
used (p = 0.019) and position in the WHO Analgesic 
Ladder (p = 0.026). All these values are confirmed by the 
statistical power and effect size of the test (Table 4). 
Table 4 – Intergroup evaluation of analgesics dosage, number of analgesics used and positions on the steps of the WHO Analgesic 
Ladder – Alfenas, MG, Brazil, 2016.
Variable Ev.
Experimental Group
(n = 11)
Mean ± SD
(Median)
Placebo Group
(n = 12)
Mean ± SD
(Median)
p-value
Power of the test
(1 – error β†)1
Effect size 2
Daily doses
1 1.36 ± 1.02(2.00)
1.50 ± 0.79
(2.00) 0.732
0.0631
0.1532
2 0.36 ± 0.50(0.00)
1.41 ± 0.99
(2.00) 0.010*
0.8461
1.3382
Number of analgesics used
1 1.27 ± 1.10(1.00)
1.33 ± 0.88
(1.00) 0.797
0.0521
0.0602
2 0.36 ± 0.50(0.00)
1.33 ± 1.07
(1.00) 0.019*
0.7341
1.1612
Step of the WHO Analgesic 
Ladder 
1 1.00 ± 0.83(1.00)
1.33 ± 1.07
(1.00) 0.742
0.1191
0.3442
2 0.36 ± 0.50(0.00)
1.33 ± 1.15
(1.00) 0.026*
0.6831
1.0932
Note: Ev.: Evaluation; *: p-value < 0.05; † β-Error. Application of the Mann-Whitney Test. 
During the study, there were no reports of major adverse 
reactions that required medical evaluations or any specific 
intervention. Some participants reported pain at the site of 
application of the needles, of slight intensity, with a maxi-
mum duration of 3 days. 
DISCUSSION
AA caused changes in the intensity and classification 
of pain. It also led to intergroup statistical differences in 
relation to medications. These changes are related to the 
reduction of the daily doses of analgesics, the number of 
medications used by the participants and their position in 
the steps of the WHO Analgesic Ladder.
In this study, the majority of the sample was composed by 
women affected by breast cancer, which is in line with world 
statistics that point to this type of cancer as the most preva-
lent among the female population(1). In addition, stages III 
and IV represent the most severe forms of the disease. Thus, 
delayed diagnosis and treatment leads to more aggressive 
therapies, poor prognosis and potential reduction of survival 
rates(22-23). It is concerning to note that 43.5% of the partici-
pants had a stage III tumor and were undergoing treatment 
for less than 1 year, which may indicate delayed diagnosis 
of the cancer and, consequently, an unfavorable prognosis.
Another fact observed is that, in general, participants had less 
than 10 years of education. According to authors(24), low school-
ing may influence the perception of pain in cancer patients, since 
many believe that pain is part of the illness process, and thus 
take too long to seek help, which can make the symptom worse.
It should be noted that, at baseline, the mean pain inten-
sity of the Experimental Group and of the Placebo Group 
was classified as moderate. However, 60.9% of the partici-
pants reported using one or no analgesics for pain manage-
ment. In this context, it is important to note that, in Brazil, 
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RESUMO
Objetivo: Avaliar a efetividade da acupuntura auricular na dor de pacientes oncológicos em tratamento quimioterápico e possíveis 
alterações no consumo de analgésicos após a aplicação da intervenção. Método: Ensaio clínico randomizado com portadores de 
câncer que apresentavam queixa de dor maior ou igual a quatro na Escala Numérica da Dor. Foram criados dois grupos paralelos, um 
Experimental, o qual recebeu a aplicação da acupuntura auricular em pontos do equilíbrio energético e em pontos indicados para o 
tratamento da dor, e um Placebo, em que foram aplicados pontos placebos fixos. Ambos os grupos receberam a aplicação de agulhas 
semipermanentes em oito sessões. Resultados: Participaram 31 portadores de câncer. Depois das oito sessões de acupuntura auricular, 
pain management is ineffective and health professionals give 
little attention to complaints of pain, treating it in a less 
effective way(25). Therefore, cancer patients are increasingly 
seeking complementary or alternative measures to manage 
symptoms during the disease(26).
Pain is a symptom whose origins vary according to the 
experiences of each individual. Thus, its treatment requires 
a comprehensive and individualized approach. However, in 
many cases, conventional or complementary therapy, when 
used in isolation, provide ineffective results when compared 
to the treatments that associate the two options(27).
Thus, with the application of AA in energy balance points 
that took into account the participant’s complaint in an indi-
vidual way, there was a reduction in pain intensity after the 
eight sessions. This result resembles that of a previous study(10), 
in which the researchers compared the effects of AA on the 
relief of cancer pain and found a significant difference between 
the group that received AA at personalized points and the 
groups that received the intervention in sham points. This 
supports the evidence that treatment with the use of specific 
and personalized points is what promotes pain relief. 
Pain management, from the perspective of CTM, must 
be performed through individual assessment, according to 
medical history, symptoms and diagnosis, directing the ther-
apy according to the patients’ complaints. This pain man-
agement, which considers the individual in a comprehensive 
manner, has shown good results(10,28). The present study, in 
agreement with these findings, found a significant reduction 
of pain. The individualized treatment, selected according to 
the energetic changes of each participant, was fundamental 
to obtain the final result, since, even though the two groups 
received the insertion of needles in the auricle, only the 
group that received the treatment from the perspective of 
the CTM obtained more satisfactory results.
With pain relief, there is a possibility of decreasing med-
ication use, reducing the adverse effects caused indirectly 
by medications. In this context, since AA is a complemen-
tary treatment that does not use drugs and offers minimum 
risks to the patient, it can contribute to the treatment of 
patients who are sensitive to analgesics or who, even with 
conventional treatment and high doses of medication, still 
complain of pain(17). 
Current studies evaluating the association between com-
plementary therapies and analgesics and its effect on the relief 
of cancer pain can be found. These studies demonstrate satis-
factory effects when these treatments are used in a combined 
manner. Their combined use decreases the time of pain relief 
and potentializes the reduction of pain intensity, while the iso-
lated treatment is not very effective(29-30). A study(30) has raised 
the possibility that the analgesia provided by acupuncture 
can be more significant than the outcomes of the medica-
tions indicated in the WHO Analgesic Ladder. In addition, 
it causes fewer adverse effects and dependence. This fact can 
be explained by the fact that the complementary treatment 
seeks an energetic balance of the individual, treating not only 
physical pain, but other aspects, such as psychological factors, 
that can influence the intensity of the symptom.
In the present study, there was a significant difference 
between the groups in relation to the daily doses of analge-
sics and the number of analgesics used. In addition, with the 
reduction of pain, there was a possibility that the analgesic 
treatment and, consequently, the classification of the patient 
on the WHO Analgesic Ladder, would change. This fact 
was verified, which demonstrates the effectiveness of AA, 
as found by other studies(29-30).
However, regardless of the choice of therapy for the 
management of cancer pain, this symptom should be treated 
and assessed in an individual and holistic manner, because 
it is a particular process influenced by different factors(31).
During the development of this study, some factors 
were considered as limitations. The scarcity of literature on 
the efficacy of AA in the treatment of cancer pain was an 
obstacle to the design of the study, a limitation that is also 
found by other authors(9,17,29). Another difficulty was the 
resistance of the population to accept the needle treatment. 
The adverse effects of chemotherapy and the complementary 
tests required during the treatment of cancer led to resched-
uling of some sessions. The expressive number of deaths since 
the beginning of the study caused a considerable sample 
loss. There were also difficulties with languages  of Eastern 
countries during literature search, which may have limited 
the comparison of findings. The existence of different views 
of AA impaired the elaboration of the treatment proto-
col, since the authors disagree on the use of the technique. 
Finally, although the follow-up evaluation was a limitation, 
the results obtained showed the importance of AA as a com-
plementary treatment of cancer pain. In addition, studies 
with larger samples are suggested.
CONCLUSION
Auricular acupuncture was effective in reducing the pain 
intensity of cancer patients receiving chemotherapy. In addi-
tion, it was associated with reduction in the consumption 
of analgesics. The technique was safe, effective, inexpensive 
and with minimal risk to participants.  
However, new studies are necessary to provide new 
evidence on the use of auricular acupuncture in the treat-
ment of cancer pain and to strengthen the acceptance of the 
technique by health professionals, especially nurses, in the 
planning of their care.
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houve diferença significativa entre os grupos na redução da intensidade da dor (p < 0,001) e no consumo das medicações (p < 0,05). 
Conclusão: A acupuntura auricular foi efetiva na redução da dor de pacientes em tratamento quimioterápico. Registro Brasileiro de 
Ensaios Clínicos: RBR-6k3rqh.
DESCRITORES
Acupuntura Auricular; Terapias Complementares; Dor; Neoplasias; Enfermagem Oncológica.
RESUMEN
Objetivo: Evaluar la efectividad de la acupuntura auricular en el dolor de pacientes oncológicos en tratamiento quimioterápico y 
posibles alteraciones en el consumo de analgésicos después de la aplicación de la intervención. Método: Ensayo clínico aleatorizado 
con portadores de cáncer que se quejaban de dolor mayor o igual a cuatro en la Escala Numérica del Dolor. Se crearon dos grupos 
paralelos, un Experimental, el cual recibió la aplicación de la acupuntura auricular en puntos del equilibrio energético y en puntos 
indicados para el tratamiento del dolor, y un Placebo, en que se aplicaron puntos placebos fijos. Ambos grupos recibieron la aplicación 
de agujas semipermanentes en ocho sesiones. Resultados: Participaron 31 portadores de cáncer. Después de las ocho sesiones de 
acupuntura auricular, hubo diferencia significativa entre los grupos en la reducción de la intensidad del dolor (p <0,001) y en el consumo 
de las medicaciones (p <0,05). Conclusión: La acupuntura auricular fue efectiva en la reducción del dolor de pacientes en tratamiento 
quimioterápico. Registro Brasileño de Ensayos Clínicos: RBR-6k3rqh.
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